[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR890003768A - 2-[(4- 피페리딜)메틸]- 벤조푸로[2,3-c]피리딘유도체, 그의 제법 및 치료에의 이용 - Google Patents

2-[(4- 피페리딜)메틸]- 벤조푸로[2,3-c]피리딘유도체, 그의 제법 및 치료에의 이용 Download PDF

Info

Publication number
KR890003768A
KR890003768A KR1019880010016A KR880010016A KR890003768A KR 890003768 A KR890003768 A KR 890003768A KR 1019880010016 A KR1019880010016 A KR 1019880010016A KR 880010016 A KR880010016 A KR 880010016A KR 890003768 A KR890003768 A KR 890003768A
Authority
KR
South Korea
Prior art keywords
pyridine
benzyl
temperature
tetrahydrobenzofuro
methylbenzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019880010016A
Other languages
English (en)
Inventor
세브랑 미레이유
조르지 파스칼
모렐 클로드
Original Assignee
에.뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에.뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에.뚜레 레메뜨르
Publication of KR890003768A publication Critical patent/KR890003768A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

내용 없음

Description

2-[(4- 피페리딜)메틸]- 벤조푸로[2,3-C]피리딘유도체, 그의 제법 및 치료에의 이용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 일반식(Ⅰ)의 화합물 및 약리학적으로 허용되는 산과의 그의 부과염.
    (Ⅰ)
    상기식에서 R은 벤질, 벤조일, 3-클로로벤조일, 3-메틸벤조일 또는 (C1-C6알콕시)카르보닐기를 나타낸다.
  2. 3,4-디히드로벤조푸로[2,3-c]피리딘을 먼저 20 내지 40℃의 온도에서 메탄올과 같은 저급지방족알코올형의 용매에서 수소화붕소나트륨과 같은 알칼리금속 수소화붕소화물에 의해 1,2,3,4-테트라히드로벤조푸로[2,3-c]피리딘으로 환원시킨다음, -R이 벤질기를 나타내는 일반식(Ⅰ)의 화합물을 위해서는, 1,2,3,4-테트라히드로벤조푸로[2,3-c]피리딘을 20 내지 40℃의 온도에서 N,N-디메틸아닐린과 같은 염기의 존재하에 디클로로메탄과 같은 바활성용매에서 1-벤질-4-피페리딘카르복실산염화물(해당산과 염화티오닐 또는 어떤 다름 대등한 약품에 의해 인시튜 제조됨)과 반응시킨 다음 이로써 얻은 2-[(1-벤질-4-피페리딜)카르보닐]-1,2,3,4-테트라히드로벤조푸로[2,3-c]피리딘을 20 내지 100℃의 온도에서, 디에틸에테르, 테트라히드로푸란, 또는 디옥산과 같은 에테르성 용매에서 디보란 또는 보란/황화메틸착제와 같은 단순 또는 착체 수소화붕소, 또는 수소화알루미늄 리튬에 의해 환원시키거나, 또는 다르게는 -R이 벤조일, 3-클로로벤조일, 3-메틸벤조일 또는 (C1-C6알콕시)카르보닐기를 나타내는 일반식(Ⅰ)의 화합물을 위해서, 1,2,3,4-테트라히드로벤조푸로[2,3-c]피리딘을 20 내지 150℃의 온도에서 디메틸포름아미드 또는 크실렌과 같은 비활성 용매의 부재, 아니면 존재하와 임의적으로 3차아민과 같은 유기염기 또는 알칼리금속 탄산염 또는 탄산수소염과 같은 무기염기의 존재하에 일반식(Ⅵ)
    (Ⅵ)
    (상기식에서 Tos는 토실기를 나타내고, R은 벤조일, 3-클로로벤조일, 3-메틸벤조일 또는 (C1-C6알콕시) 카르보닐기를 나타낸다)의 토실레이트와 반응시키는 것을 특징으로 하는 제1항에 따르는 화합물의 제조방법.
  3. 제1항에 따르는 화합물을, 적합한 부형제와 조합하여 함유하는 것을 특징으로 하는 약학조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880010016A 1987-08-07 1988-08-05 2-[(4- 피페리딜)메틸]- 벤조푸로[2,3-c]피리딘유도체, 그의 제법 및 치료에의 이용 Withdrawn KR890003768A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8711287 1987-08-07
FR8711287A FR2619112B1 (fr) 1987-08-07 1987-08-07 Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
KR890003768A true KR890003768A (ko) 1989-04-18

Family

ID=9354025

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880010016A Withdrawn KR890003768A (ko) 1987-08-07 1988-08-05 2-[(4- 피페리딜)메틸]- 벤조푸로[2,3-c]피리딘유도체, 그의 제법 및 치료에의 이용

Country Status (17)

Country Link
US (1) US4931449A (ko)
EP (1) EP0302787B1 (ko)
JP (1) JPS6466187A (ko)
KR (1) KR890003768A (ko)
AT (1) ATE69054T1 (ko)
AU (1) AU597187B2 (ko)
DE (1) DE3865917D1 (ko)
DK (1) DK437688A (ko)
FI (1) FI883668L (ko)
FR (1) FR2619112B1 (ko)
GR (1) GR3003375T3 (ko)
HU (1) HU201075B (ko)
IL (1) IL87338A (ko)
NO (1) NO166788C (ko)
NZ (1) NZ225707A (ko)
PT (1) PT88205B (ko)
ZA (1) ZA885787B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3902372A1 (de) * 1989-01-27 1990-08-02 Hoechst Ag Verfahren zur herstellung von d((pfeil hoch)+(pfeil hoch))-2-(4-acetylphenoxy)- propionsaeureestern
FR2661178B1 (fr) * 1990-04-24 1993-03-12 Synthelabo Derives de [(tetrahydro-1,2,3,4 isoquinoleinyl-2)methyl]-4 piperidinecarboxylates-1 d'alkyle, leur preparation et leur application en therapeutique.
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
WO2008100443A2 (en) * 2007-02-09 2008-08-21 Bright View Technologies, Inc. High contrast liquid crystal displays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161218B1 (de) * 1984-05-10 1991-06-26 Ciba-Geigy Ag Benzo-(pyrano und thiopyrano)-pyridine
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate

Also Published As

Publication number Publication date
FI883668A7 (fi) 1989-02-08
FI883668A0 (fi) 1988-08-05
GR3003375T3 (en) 1993-02-17
PT88205B (pt) 1995-05-04
NO883486L (no) 1989-02-08
FR2619112A1 (fr) 1989-02-10
IL87338A0 (en) 1989-01-31
JPS6466187A (en) 1989-03-13
ATE69054T1 (de) 1991-11-15
IL87338A (en) 1992-01-15
HU201075B (en) 1990-09-28
FI883668L (fi) 1989-02-08
ZA885787B (en) 1989-04-26
DK437688A (da) 1989-02-08
US4931449A (en) 1990-06-05
PT88205A (pt) 1989-06-30
HUT47939A (en) 1989-04-28
AU2044488A (en) 1989-02-09
NO166788B (no) 1991-05-27
EP0302787B1 (fr) 1991-10-30
AU597187B2 (en) 1990-05-24
FR2619112B1 (fr) 1989-11-17
DE3865917D1 (de) 1991-12-05
NZ225707A (en) 1989-11-28
DK437688D0 (da) 1988-08-05
NO166788C (no) 1991-09-04
NO883486D0 (no) 1988-08-05
EP0302787A1 (fr) 1989-02-08

Similar Documents

Publication Publication Date Title
US4656182A (en) Substituted trans-1,2-diaminocyclohexyl amide compounds
US3822258A (en) 4-hydroxy-3-(3-isoxazolylcarbamoyl)-2h-1,2-benzothiazine 1,1-dioxides and process for their production
ES391497A1 (es) Procedimiento para la preparacion de nuevos derivados de ciclohepteno.
KR890005086A (ko) 1-[(2- 피리미디닐) 아미노알킬]피페리딘, 그의 제법 및 치료에의 이용
KR890003768A (ko) 2-[(4- 피페리딜)메틸]- 벤조푸로[2,3-c]피리딘유도체, 그의 제법 및 치료에의 이용
KR860007201A (ko) 항생 작용을 갖는 악타가르딘의 염기성 모노카르복시아미드 유도체의 제조방법
Biel Antihistaminics. I. Some Ethylene Diamines and an Aminoether
KR890016044A (ko) 트랜스-헥사하이드로-8-하이드록시-2,6-메타노-2h-퀴놀리진-3(4h)-온의 인돌-3-카복실산 에스테르의 제조방법
KR900001685A (ko) [(4-피페리딜)메틸]-2,3-디히드로-1h-이소인돌 및 -2,3,4,5- 테트라히드로-1h-벤즈아제핀 유도체, 그의 제조 및 치료요법에 있어서의 그의 작용
GB984119A (en) Substituted piperidines and methods for their preparation
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
NO139050B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
KR870004962A (ko) 헤테로사이클릭 화합물의 제조방법
US4115387A (en) 3-Methyl-4-phenyl-1,2,3,4-tetrahydrobenz [H]isoquinoline hydrobromide
KR910016706A (ko) 카보닐함유 아크리딘의 환원 방법
IE60479B1 (en) Berban derivatives and their preparation and pharmaceutical formulation
GB1106742A (en) New piperidine derivatives and the homologues thereof and process for their production
Turner et al. Synthesis of two metabolites of (+)-propoxyphene
KR880007465A (ko) N-(4-피페리딜)벤즈아미드 및 그 염의 제조방법
US3551430A (en) Esters of hexahydro - 9,10 - dialkoxy - 2h-benzo(a)quinolizine-1-propionic acid
US3136778A (en) 1-[(omega oxy-lower alkyl)]-2-methyl-3-phenyl-3-propionyloxy-pyrrolidines
KR870005998A (ko) 아조니아스피로노르트로판올 에스테르의 제조 방법
US3138614A (en) Salts of 1, 1-dimethyl-3-pyrrolidyl phenyl-2-thienylglycolate
GB1440380A (en) Pyrrolidine derivatives
GB917817A (en) New phenothiazine derivatives and processes for producing such derivatives

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880805

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid